Axsome Therapeutics Stock Jumped: April Rally and What It Means for Investors
Axsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
Optimizing your budget with zero-based techniques can significantly improve cash flow. Explore methods that work for you.
23,484 articlesAxsome Therapeutics rode a powerful April rally driven by Auvelity performance and pipeline momentum. This article br...
In a pivotal speech, the former chair jerome powell sends a clear message about inflation and political pressure. Inv...
AMD faces another round of upgrades as AI infrastructure spending keeps demand alive. Analysts raise targets while in...
C3.ai reports after the bell, with traders watching for signals on revenue, margins and AI platform uptake. This live...
This is the second installment of our wealth series. Discover practical habits, disciplined saving, and smart investi...
A Ligand Pharmaceuticals insider recently sold 5,000 shares, triggering discussions about what insider moves signal f...
As Berkshire's new investment captain, Greg Abel faces a pivotal test: can his Q2 moves in Alphabet, Mitsubishi, Maru...
Market volatility and evolving rates are shaping retirement planning. This report highlights dividend growth ETFs tun...
Rigetti's Q1 earnings tonight could shape the next move for its stock as Novera shipments and Cepheus milestones feed...
Target shares surged to a fresh all-time high after a robust Q1 report, sparking questions about how long the rally c...
Point closes $508.6m securitization, the largest HEI-backed deal to date, as institutional buyers pile into home equi...
Zillow's latest forecast for 2026 hints at a shifting housing landscape. This guide breaks down what it means for mor...